You are here
CERID Bibliography
The murine intravaginal HSV-2 challenge model for investigation of DNA vaccines. Methods Mol Biol. 2014 ;1144:305-27.
. A Novel DNA Vaccine Technology Conveying Protection against a Lethal Herpes Simplex Viral Challenge in Mice. PLoS One. 2013 ;8(10):e76407.
. Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine. J Clin Invest. 2012 ;122(2):654-73.
Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection. J Gen Virol. 2012 ;93(Pt 6):1305-15.
. Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood. Clin Cancer Res. 2011 ;17(21):6671-80.
DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge. Vaccine. 2010 ;28(47):7483-91.
. Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays. J Control Release. 2010 ;148(3):327-33.
Public TCR use by herpes simplex virus-2-specific human CD8 CTLs. J Immunol. 2010 ;184(6):3063-71.
. Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection. J Gen Virol. 2009 ;90(Pt 5):1153-63.